This brief details the federal programs that are affected by the Hyde Amendment and laws and regulations that have a similar goal, provides estimates on the share of women insured by Medicaid affected by the law, reviews the impact of the law on their access to abortion services, and discusses the potential effect if the law were to be repealed.| KFF
The Abortion in the U.S. Dashboard is an ongoing research project tracking state abortion policies and litigation following the overturning of Roe v. Wade.| KFF
The Supreme Court will be hearing oral arguments for the case FDA v. Alliance for Hippocratic Medicine. This brief explains the issues at stake before the court and their implications for the drug regulatory process and medication abortion access throughout the country.| KFF
New Guttmacher Institute research from the Monthly Abortion Provision Study shows that there were approximately 642,700 medication abortions in the United States in 2023, accounting for 63% of all abortions in the formal health care system. This is an increase from 2020, when medication abortions accounted for 53% of all abortions. | Guttmacher Institute
Use of medication abortion in the formal US health care system has risen substantially from 53% of all abortions in 2020 to 63% in 2023. In the first full calendar year following the US Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision, approximately 642,700 medication abortions took place within the health care system, according to new data from the Guttmacher Institute’s Monthly Abortion Provision Study. | Guttmacher Institute
Fact sheet on abortion: scope of the problem, consequences of inaccessible quality abortion care, expanding quality abortion care, and WHO action.| www.who.int